To further elucidate the elraglusib-mediated effects on tumor cell survival we probed for survival factors Bcl-2 and Survivin and noted decreases in protein expression in both cell lines, especially at the later timepoints (48, 72 h). Here, BCL2 is linked to neoplasm.